Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- N/A
Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Voxelotor Neurocognitive Function Study
- Status
- TERMINATED
- Phase
- PHASE3
Voxelotor Brain Oxygenation and Neurocognitive Study
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza
- Status
- COMPLETED
- Phase
- PHASE1
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
- Status
- COMPLETED
- Phase
- PHASE4
A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955
- Status
- COMPLETED
- Phase
- PHASE1
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
- Status
- RECRUITING
- Phase
- PHASE4